The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland

被引:324
作者
Davies, Andrew N. [1 ]
Dickman, Andrew [2 ]
Reid, Colette
Stevens, Anna-Marie [3 ]
Zeppetella, Giovambattista
机构
[1] Royal Marsden NHS Fdn Trust, Dept Palliat Med, Sutton SM2 5PT, Surrey, England
[2] Marie Curie Palliat Care Inst, Liverpool, Merseyside, England
[3] Royal Marsden NHS Fdn Trust, London, England
关键词
Pain; Breakthrough pain; Cancer; Palliative care; TRANSMUCOSAL FENTANYL CITRATE; PATIENT-CONTROLLED ANALGESIA; INCIDENT PAIN; INTRAVENOUS MORPHINE; HOSPICE PATIENTS; BONE METASTASES; DOSE-TITRATION; EPISODIC PAIN; DOUBLE-BLIND; CASE SERIES;
D O I
10.1016/j.ejpain.2008.06.014
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) was convened to produce some up-to-date, evidence-based, practical, clinical guidelines on the management of cancer-related breakthrough pain in adults. On the basis of a review of the literature, the task group was unable to make recommendations about an individual interventions, but was able to make a series of 12 recommendations about certain generic strategies. However, most of the aforementioned recommendations are based on limited evidence (i.e., case series, expert opinion). The task group also proposed a definition of breakthrough pain, and some diagnostic criteria for breakthrough pain. (c) 2008 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 58 条
[1]  
[Anonymous], 2006, CANC RELATED BREAKTH
[2]  
Bailey F, 2006, CANC RELATED BREAKTH, P43
[3]  
Bennett D., 2005, P T, V30, P354
[4]   A PROSPECTIVE MULTICENTER ASSESSMENT OF THE EDMONTON STAGING SYSTEM FOR CANCER PAIN [J].
BRUERA, E ;
SCHOELLER, T ;
WENK, R ;
MACEACHERN, T ;
MARCELINO, S ;
HANSON, J ;
SUAREZALMAZOR, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (05) :348-355
[5]   THE USE OF METHYLPHENIDATE IN PATIENTS WITH INCIDENT CANCER PAIN RECEIVING REGULAR OPIATES - A PRELIMINARY-REPORT [J].
BRUERA, E ;
FAINSINGER, R ;
MACEACHERN, T ;
HANSON, J .
PAIN, 1992, 50 (01) :75-77
[6]   Percutaneous vertebroplasty - A technique to treat refractory spinal pain in the setting of advanced metastatic cancer: A case series [J].
Burton, AN ;
Reddy, SK ;
Shah, HN ;
Tremont-Lukats, I ;
Mendel, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 30 (01) :87-95
[7]   Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study [J].
Carr, DB ;
Goudas, LC ;
Denman, WT ;
Brookoff, D ;
Staats, PS ;
Brennen, L ;
Green, G ;
Albin, R ;
Hamilton, D ;
Rogers, MC ;
Firestone, L ;
Lavin, PT ;
Mermelstein, F .
PAIN, 2004, 108 (1-2) :17-27
[8]  
CHRISTELIS N, 2006, CANC RELATED BREAKTH, P97
[9]   Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain [J].
Christie, JM ;
Simmonds, M ;
Patt, R ;
Coluzzi, P ;
Busch, MA ;
Nordbrock, E ;
Portenoy, RK .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3238-3245
[10]   Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®) [J].
Coluzzi, PH ;
Schwartzberg, L ;
Conroy, JD ;
Charapata, S ;
Gay, M ;
Busch, MA ;
Chavez, J ;
Ashley, J ;
Lebo, D ;
McCracken, M ;
Portenoy, RK .
PAIN, 2001, 91 (1-2) :123-130